Info

aya all

  1. Goekbuget N, Stoltefuß A, Topp MS, et al. Dose Reduced Chemotherapy in Sequence with Blinatumomab for Newly Diagnosed Older Patients with B-Precursor Adult Lymphoblastic Leukemia (ALL): Results of the Ongoing GMALL Bold Trial. Blood. 2021;138(Supplement 1):3399-3399. doi:https://doi.org/10.1182/blood-2021-146214
  2. Aldoss I. Revumenib Monotherapy in Patients with Relapsed/Refractory KMT2Ar Acute Leukemia: Topline Efficacy and Safety Results from the Pivotal Augment-101 Phase 2 Study. Confex.com. Published 2023. Accessed January 21, 2024. https://ash.confex.com/ash/2023/webprogram/Paper192042.html
  3. Revumenib